Silk Road Medical ticks higher as HSR waiting period for Boston Scientific sale expires - MSN

Silk Road Medical (NASDAQ:SILK) edged higher by 0.7% in premarket trading after the HSR waiting period for its planned sale to Boston Scientific (BSX) expired. The waiting period expired on ... Read More

Boston Scientific withdraws Silk Road Medical HSR filing, will refile - MSN

Boston Scientific (BSX) disclosed that it withdrew and will refile its HSR notification for its planned purchase of Silk Road Medical (NASDAQ:SILK). The filing was withdrawn on Friday and will be ... Read More

Boston Scientific (BSX), Silk Road Merger Delayed for Review

Boston Scientific’s HSR Filing was withdrawn effective as of Aug 9, and Boston Scientific expects to refile on Aug 13, 2024. Upon refiling on that date, a new 30-day waiting period under the HSR ... Read More

Boston Scientific closes Silk Road Medical acquisition

Boston Scientific and Silk Road Medical expect their $1.26 billion merger to close in the “coming days,” nearly three months after the acquisition was announced. Read More

Silk Road Medical set to complete merger with Boston Scientific

Silk Road Medical Inc (NASDAQ:SILK), a company specializing in medical instruments and apparatus, is on the verge of becoming a wholly-owned subsidiary of Boston Scientific Corporation (NYSE:BSX ... Read More

Boston Scientific snags Silk Road Medical in $1.26B deal - Fierce Biotech

Boston Scientific is en route to expand its vascular offerings with a $1.26 billion deal to acquire Silk Road Medical and its approach to reducing the risk of stroke via carotid artery procedures. Read More

Boston Scientific to Buy Silk Road Medical for $1.26B

On Tuesday, the medical device giant announced plans to buy California-based Silk Road Medical for about $1.26 billion. In a news release, Boston Scientific said the enterprise value of the deal ... Read More

Boston Scientific to Buy Silk Road Medical for About $1.26 Billion - WSJ - The Wall Street Journal

Boston Scientific has struck a deal to buy medical-device maker Silk Road Medical for about $1.26 billion, adding a technology for stroke prevention to its vascular portfolio. Read More

Boston Scientific withdraws Silk Road Medical HSR filing, will refile

Boston Scientific in June announced a deal to acquire medical device company Silk Road Medical f or $27.50 a share, representing an enterprise value of approximately $1.16B. More on Silk Road Medical ... Read More

Boston Scientific (BSX), Silk Road Merger Delayed for Review

Boston Scientific BSX recently elected to voluntarily withdraw and refile its Premerger Notification and Report Form (the "HSR Filing") under the Hart-Scott-Rodino Antitrust Improvements Act of ... Read More